| Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route R Pathak, RP Dash, M Misra, M Nivsarkar Acta Pharmaceutica Sinica B 4 (2), 151-160, 2014 | 115 | 2014 |
| Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats V Zunjar, RP Dash, M Jivrajani, B Trivedi, M Nivsarkar Journal of ethnopharmacology 181, 20-25, 2016 | 105 | 2016 |
| Gastrointestinal-resident, shape-changing microdevices extend drug release in vivo A Ghosh, L Li, L Xu, RP Dash, N Gupta, J Lam, Q Jin, V Akshintala, ... Science advances 6 (44), eabb4133, 2020 | 86 | 2020 |
| Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: an insight from the published in vitro, preclinical and clinical studies RP Dash, R Jayachandra Babu, NR Srinivas European journal of drug metabolism and pharmacokinetics 42, 915-933, 2017 | 76 | 2017 |
| N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated … MT Nedelcovych, L Tenora, BH Kim, J Kelschenbach, W Chao, E Hadas, ... Journal of medicinal chemistry 60 (16), 7186-7198, 2017 | 71 | 2017 |
| Two decades-long journey from riluzole to edaravone: Revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics RP Dash, NR Babu, R Jayachandra, Srinivas Clinical Pharmacokinetics, 2018 | 67 | 2018 |
| Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 … RP Dash, RJ Babu, NR Srinivas Xenobiotica 48 (1), 89-108, 2018 | 56 | 2018 |
| Critical assessment of pharmacokinetic drug–drug interaction potential of tofacitinib, baricitinib and upadacitinib, the three approved janus kinase inhibitors for rheumatoid … V Veeravalli, RP Dash, JA Thomas, RJ Babu, LMV Madgula, NR Srinivas Drug safety 43, 711-725, 2020 | 48 | 2020 |
| Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug R Rais, KM Lemberg, L Tenora, ML Arwood, A Pal, J Alt, Y Wu, J Lam, ... Science advances 8 (46), eabq5925, 2022 | 47 | 2022 |
| Comparative pharmacokinetic profiles of picrosides I and II from kutkin, Picrorhiza kurroa extract and its formulation in rats D Upadhyay, RP Dash, S Anandjiwala, M Nivsarkar Fitoterapia 85, 76-83, 2013 | 43 | 2013 |
| N-substituted prodrugs of mebendazole provide improved aqueous solubility and oral bioavailability in mice and dogs SC Zimmermann, T Tichý, J Vávra, RP Dash, EC Slusher, AJ Gadiano, ... Journal of Medicinal Chemistry, 2018 | 42 | 2018 |
| Simultaneous quantification of berberine and lysergol by HPLC‐UV: evidence that lysergol enhances the oral bioavailability of berberine in rats S Patil, RP Dash, S Anandjiwala, M Nivsarkar Biomedical Chromatography 26 (10), 1170-1175, 2012 | 42 | 2012 |
| Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs L Tenora, J Alt, RP Dash, AJ Gadiano, K Novotna, V Veeravalli, J Lam, ... Journal of medicinal chemistry 62 (7), 3524-3538, 2019 | 39 | 2019 |
| Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for Alzheimer’s disease M Šála, KR Hollinger, AG Thomas, RP Dash, C Tallon, V Veeravalli, ... Journal of medicinal chemistry 63 (11), 6028-6056, 2020 | 36 | 2020 |
| Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes SR Sagar, JK Agarwal, DH Pandya, RP Dash, M Nivsarkar, KK Vasu Bioorganic & Medicinal Chemistry Letters 25 (20), 4428-4433, 2015 | 36 | 2015 |
| Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic RP Dash, RJ Babu, NR Srinivas Infectious Diseases 49 (7), 483-492, 2017 | 34 | 2017 |
| A novel and potent brain penetrant inhibitor of extracellular vesicle release C Rojas, M Sala, AG Thomas, A Datta Chaudhuri, SW Yoo, Z Li, RP Dash, ... British journal of pharmacology 176 (19), 3857-3870, 2019 | 33 | 2019 |
| Glutamine antagonist JHU083 normalizes aberrant glutamate production and cognitive deficits in the EcoHIV murine model of HIV-associated neurocognitive disorders MT Nedelcovych, BH Kim, X Zhu, LE Lovell, AA Manning, J Kelschenbach, ... Journal of Neuroimmune Pharmacology 14, 391-400, 2019 | 31 | 2019 |
| Use of sorbitol as pharmaceutical excipient in the present day formulations–issues and challenges for drug absorption and bioavailability RP Dash, NR Srinivas, RJ Babu Drug development and industrial pharmacy 45 (9), 1421-1429, 2019 | 31 | 2019 |
| Evaluation of GABAergic transmission modulation as a novel functional target for Management of Multiple Sclerosis: Exploring inhibitory effect of GABA on glutamate‐mediated … AA Gilani, RP Dash, MN Jivrajani, SK Thakur, M Nivsarkar Advances in Pharmacological and Pharmaceutical Sciences 2014 (1), 632376, 2014 | 26 | 2014 |
Rana RaisAssociate Professor, Johns Hopkins在 jhmi.edu 的电子邮件经过验证
